These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2900845)
21. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population. Lau RC N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227 [TBL] [Abstract][Full Text] [Related]
22. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Versteegh FG; Mertens PL; de Melker HE; Roord JJ; Schellekens JF; Teunis PF Epidemiol Infect; 2005 Aug; 133(4):737-48. PubMed ID: 16050521 [TBL] [Abstract][Full Text] [Related]
23. Dissecting human T cell responses against Bordetella species. De Magistris MT; Romano M; Nuti S; Rappuoli R; Tagliabue A J Exp Med; 1988 Oct; 168(4):1351-62. PubMed ID: 2902185 [TBL] [Abstract][Full Text] [Related]
24. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens. Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718 [TBL] [Abstract][Full Text] [Related]
25. Effect of erythromycin treatment on antibody responses in pertussis. Granström G; Granström M Scand J Infect Dis; 1994; 26(4):453-7. PubMed ID: 7984978 [TBL] [Abstract][Full Text] [Related]
26. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. Zackrisson G; Taranger J; Trollfors B J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488 [TBL] [Abstract][Full Text] [Related]
27. Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides. Chong P; Zobrist G; Sia C; Loosmore S; Klein M Infect Immun; 1992 Nov; 60(11):4640-7. PubMed ID: 1383153 [TBL] [Abstract][Full Text] [Related]
28. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis. Oguchi K; Miyata A; Kazuyama Y; Noda A; Suzuki E; Watanabe M; Nakayama T J Infect Chemother; 2015 Sep; 21(9):639-46. PubMed ID: 26134278 [TBL] [Abstract][Full Text] [Related]
29. Quantitation of pertussis toxin in an enzyme linked immunosorbent assay with improved specificity. Ibsen P; Heron I Biologicals; 1990 Apr; 18(2):123-6. PubMed ID: 2375859 [TBL] [Abstract][Full Text] [Related]
30. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077 [TBL] [Abstract][Full Text] [Related]
31. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos. Calver GA Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203 [TBL] [Abstract][Full Text] [Related]
32. Serum antibody response to B. pertussis Tn5 mutants, purified PT and FHA in two different mouse strains and passive protection in the murine intranasal infection model. Olander RM; Muotiala A; Karvonen M; Kuronen T; Runeberg-Nyman K Microb Pathog; 1990 Jan; 8(1):37-45. PubMed ID: 2159104 [TBL] [Abstract][Full Text] [Related]
33. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines. Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807 [TBL] [Abstract][Full Text] [Related]
34. Specific anti-Bordetella pertussis activities in human blood examined by enzyme-linked immunoassay and biological assay. Marley PB; Wilson JV; Habel H; Blaskett A Dev Biol Stand; 1985; 61():341-52. PubMed ID: 2872123 [TBL] [Abstract][Full Text] [Related]
35. Antibodies to pertussis antigens in pediatric health care workers. Riffelmann M; Koesters K; Saemann-Ischenko G; Schmitt HJ; Wirsing von Koenig CH Pediatr Infect Dis J; 2002 May; 21(5):381-3. PubMed ID: 12150172 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of enzyme-linked immunosorbent assay for rapid diagnosis of Bordetella pertussis infection. Lawrence AJ; Paton JC J Clin Microbiol; 1987 Nov; 25(11):2102-4. PubMed ID: 2891724 [TBL] [Abstract][Full Text] [Related]
37. A sensitive method for measuring neutralizing antibodies to Bordetella pertussis toxin: optimized ADP-ribosylation of transducin. Magnusson R; Larsson U; Bartfai T; Askelöf P Biologicals; 1991 Jan; 19(1):9-15. PubMed ID: 2049177 [TBL] [Abstract][Full Text] [Related]
38. Correlation of IgA, IgM and IgG antibody-detecting assays based on filamentous haemagglutinin, pertussis toxin and Bordetella pertussis sonicate in a strictly adult population. Klement E; Kagan N; Hagain L; Kayouf R; Boxman J; Cohen D; Orr N Epidemiol Infect; 2005 Feb; 133(1):149-58. PubMed ID: 15724722 [TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children. Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630 [TBL] [Abstract][Full Text] [Related]
40. [A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine]. Zakharova NS; Shmeleva EI; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Mertsalova NU; Britsina MV; Ermolova EV; Zaĭtsev EM Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):70-2. PubMed ID: 9304336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]